Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
07/03/1996 | CN1125575A Adhesion receptor antagonists |
07/03/1996 | CN1032205C Process of preparing purinyl and pyrimidinyl-cyclo butane derivatives |
07/02/1996 | US5532359 Fungicides |
07/02/1996 | US5532248 O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity |
07/02/1996 | US5532233 Platelet activating factor antagonist |
07/02/1996 | US5532221 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention |
07/02/1996 | US5532215 Antiviral compositions and method of use |
07/02/1996 | US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof |
07/02/1996 | US5532154 Mutated alpha virus |
07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
07/02/1996 | CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs |
07/01/1996 | CA2166371A1 Avian herpesvirus-based live recombinant avian vaccine, in particular against gumboro disease |
06/27/1996 | WO1996019580A2 Telomerase protein component |
06/27/1996 | WO1996019498A2 T cell stimulating protein of pestivirus |
06/27/1996 | WO1996019496A1 Variants of human papilloma virus antigens |
06/27/1996 | WO1996019495A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
06/27/1996 | WO1996019494A1 Peptides having immunomodulatory activity |
06/27/1996 | WO1996019482A1 Thienoxazinone derivatives useful as antiviral agents |
06/27/1996 | WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications |
06/27/1996 | WO1996019472A1 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same |
06/27/1996 | WO1996019467A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents |
06/27/1996 | WO1996019460A1 2-carbamoyl-1,4,5,6-tetrahydropyrazines |
06/27/1996 | WO1996019437A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
06/27/1996 | DE4446025A1 2-Caroxamido-1,4,5,6-tetrahydropyrazine 2-Caroxamido-1,4,5,6-tetrahydropyrazine |
06/27/1996 | CA2419289A1 Variants of human papilloma virus antigens |
06/27/1996 | CA2208518A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents |
06/27/1996 | CA2208458A1 Thienoxazinone derivatives useful as antiviral agents |
06/27/1996 | CA2206778A1 Peptides having immunomodulatory activity |
06/26/1996 | EP0718400A2 Methods and compositions for controlling translation of HCV proteins |
06/26/1996 | EP0718296A1 Thermodynamically stable form of N- 4- 2-(2,4-dimethyl phenoxy)-phenyl -2-thiazolyl -1,4,5,6-tetrahydro-2-pyrimidine (DTTP) |
06/26/1996 | EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies |
06/26/1996 | EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent |
06/26/1996 | EP0717777A1 Salmonella vaccines |
06/26/1996 | EP0717774A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
06/26/1996 | EP0717752A1 Therapeutic compounds |
06/26/1996 | EP0717750A1 Double-stranded peptide nucleic acids |
06/26/1996 | EP0717738A1 Substituted oxazine and thiazine oxazolidinone antimicrobials |
06/26/1996 | EP0717731A1 Difluoro statone antiviral analogs |
06/26/1996 | EP0717628A1 Nucleosides with anti-hepatitis b virus activity |
06/26/1996 | EP0717622A1 Methods of treating hiv with azaspiranes |
06/26/1996 | EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use |
06/26/1996 | CN1125479A Ligands for FLT3 receptors |
06/26/1996 | CN1125466A Processes for producing an enzyme |
06/26/1996 | CN1125436A Vitamin D amide derivatives |
06/26/1996 | CN1125400A Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
06/26/1996 | CN1125138A Chinese proprietary medicine for curing cold |
06/25/1996 | US5530132 Viricides, hiv virus |
06/25/1996 | US5530116 Antimicrobial quinolonyl lactams |
06/25/1996 | US5530103 Method for the purification of PC protein from Borrelia burgdorferi |
06/25/1996 | US5530101 Humanized immunoglobulins |
06/25/1996 | US5530004 Antimycobacterial method |
06/25/1996 | US5529998 Antibacterial medicaments |
06/25/1996 | US5529924 Biologically pure streptomyces microorganism |
06/25/1996 | US5529771 Leukoregulin anti-herpes treatment |
06/25/1996 | US5529770 Viscous liquid conditioning topical germicides |
06/24/1996 | EP0724571A4 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
06/20/1996 | WO1996018633A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity |
06/20/1996 | WO1996018628A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds |
06/20/1996 | WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
06/20/1996 | WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
06/20/1996 | WO1996018414A1 Acellular anti-bordetella vaccine |
06/20/1996 | WO1996018396A1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections |
06/20/1996 | WO1996018393A1 Novel compounds |
06/20/1996 | WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
06/20/1996 | WO1996015234A3 Lipid-splitting enzyme |
06/20/1996 | WO1996014314A3 Thiepane compounds inhibiting and detecting hiv protease |
06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
06/20/1996 | CA2207029A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity |
06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
06/19/1996 | EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use |
06/19/1996 | EP0716856A2 Therapeutic uses of 2',5'-oligoadenylate derivatives |
06/19/1996 | EP0716852A1 Pharmaceutical formulations of cefaclor |
06/19/1996 | EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication |
06/19/1996 | EP0716613A1 TREATMENT OF $i(H. PYLORI) ASSOCIATED GASTRODUODENAL DISEASE |
06/19/1996 | EP0716605A1 Blocking the accumulation of germs on human cells |
06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
06/19/1996 | EP0716601A1 Use of thiol compounds in the therapy of viral diseases |
06/19/1996 | EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
06/19/1996 | EP0516725B1 New use of linomide (r) |
06/19/1996 | CN1124980A Modified oligonucleotides having improved anti-influenza activity |
06/19/1996 | CN1124958A Triazole derivative or salt thereof, and fungicide containing the same |
06/18/1996 | US5527910 Bactericides; staphylococcus, streptococcus infections |
06/18/1996 | US5527900 Viricides; anti-htlv activity |
06/18/1996 | US5527829 HIV protease inhibitors |
06/18/1996 | US5527805 Dna-cleaving, cytotoxic and anti-tumor compounds |
06/18/1996 | US5527803 Immunosuppressants, phosphorylase inhibitors |
06/18/1996 | US5527799 HIV protease inhibitors useful for the treatment of AIDS |
06/18/1996 | US5527793 Antibiotic carbapenem compounds |
06/18/1996 | US5527791 Carbapenem antibiotic compounds |
06/18/1996 | US5527781 Aminoglycoside antibiotics |
06/18/1996 | US5527780 Bactericides |
06/18/1996 | US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
06/18/1996 | CA2022681C 2-(2-vinylpyrrolidinylthio)carbapenem derivatives |
06/18/1996 | CA2020878C Antitumor antibiotic bu-3285t |
06/14/1996 | CA2158511A1 Pharmaceutical formulations of cefaclor |
06/13/1996 | WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms |